Literature DB >> 22964723

Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.

Ana A Weil1, Fahima Chowdhury, Ashraful I Khan, Daniel T Leung, Taher Uddin, Yasmin Ara Begum, Nirod Chandra Saha, Richelle C Charles, Regina C Larocque, Jason B Harris, Edward T Ryan, Firdausi Qadri, Stephen B Calderwood.   

Abstract

Vibriocidal antibody is a marker of recent exposure to Vibrio cholerae O1 infection. We examined vibriocidal titers for 1 year after an episode of severe cholera in patients in Dhaka, Bangladesh; 16 of 53 (30%) patients had a fourfold or greater increase in vibriocidal titer between 6 and 12 months after an episode of severe cholera, suggesting reexposure to the organism. Among patients with rises in titers during follow-up, the patients initially infected with serotype Ogawa had earlier rises in titer than the patients initially infected with serotype Inaba. These data and others suggest that an episode of severe cholera protects against symptomatic disease for several years, but reexposure to the organism occurs frequently in an endemic area, with immunological boosts beginning as early as 6 months after severe disease. Repeated exposures to V. cholerae in endemic areas may be a necessary component for long-lasting protection against severe disease.

Entities:  

Mesh:

Year:  2012        PMID: 22964723      PMCID: PMC3516269          DOI: 10.4269/ajtmh.2012.12-0323

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  Significance of vibriocidal antibodies with regard to immunity to cholera.

Authors:  E J Gangarosa; W E DeWitt; J C Feeley; M R Adams
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

2.  Cholera reinfection in man.

Authors:  W E Woodward
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

3.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Authors:  C O Tacket; M B Cohen; S S Wasserman; G Losonsky; S Livio; K Kotloff; R Edelman; J B Kaper; S J Cryz; R A Giannella; G Schiff; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Natural cholera infection-derived immunity in an endemic setting.

Authors:  Mohammad Ali; Michael Emch; Jin Kyung Park; Mohammad Yunus; John Clemens
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

6.  Duration of infection-derived immunity to cholera.

Authors:  M M Levine; R E Black; M L Clements; L Cisneros; D R Nalin; C R Young
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

Review 7.  Mechanisms of disease and immunity in cholera: a review.

Authors:  J Holmgren; A M Svennerholm
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

8.  Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.

Authors:  Debasish Saha; Regina C LaRocque; Ashraful I Khan; Jason B Harris; Yasmin Ara Begum; Syed M Akramuzzaman; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

9.  Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae.

Authors:  W H Mosley; W M McCormack; A Ahmed; A K Chowdhury; R K Barui
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

10.  The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.

Authors:  W H Mosley; S Ahmad; A S Benenson; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  6 in total

1.  Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Authors:  Kamrul Islam; Motaher Hossain; Meagan Kelly; Leslie M Mayo Smith; Richelle C Charles; Taufiqur Rahman Bhuiyan; Pavol Kováč; Peng Xu; Regina C LaRocque; Stephen B Calderwood; Jakub K Simon; Wilbur H Chen; Douglas Haney; Michael Lock; Caroline E Lyon; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2018-04-06

2.  Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey.

Authors:  Andrew S Azman; Stephen A Lauer; Taufiqur Rahman Bhuiyan; Francisco J Luquero; Daniel T Leung; Sonia T Hegde; Jason B Harris; Kishor Kumar Paul; Fatema Khaton; Jannatul Ferdous; Justin Lessler; Henrik Salje; Firdausi Qadri; Emily S Gurley
Journal:  Lancet Microbe       Date:  2020-12

3.  Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.

Authors:  M Hasanul Kaisar; Mohammed Saruar Bhuiyan; Richelle C Charles; Taufiqur Rahman Bhuiyan; Aklima Akter; Danial Saleem; Anita S Iyer; Pinki Dash; Al Hakim; Fahima Chowdhury; Ashraful Islam Khan; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  mSphere       Date:  2021-04-28       Impact factor: 4.389

Review 4.  Long-Term Kinetics of Serological Antibodies against Vibrio cholerae Following a Clinical Cholera Case: A Systematic Review and Meta-Analysis.

Authors:  Basilua Andre Muzembo; Kei Kitahara; Debmalya Mitra; Ayumu Ohno; Shin-Ichi Miyoshi
Journal:  Int J Environ Res Public Health       Date:  2022-06-10       Impact factor: 4.614

5.  Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh.

Authors:  Brie Falkard; Taher Uddin; M Arifur Rahman; Molly F Franke; Amena Aktar; Muhammad Ikhtear Uddin; Taufiqur Rahman Bhuiyan; Daniel T Leung; Richelle C Charles; Regina C Larocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

6.  Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.

Authors:  Firdausi Qadri; Ana A Weil; Denise Chac; Taufiqur R Bhuiyan; Amit Saha; Mohammad M Alam; Umme Salma; Nusrat Jahan; Fahima Chowdhury; Ashraful I Khan; Edward T Ryan; Regina LaRocque; Jason B Harris
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.